Cargando…
Treatment of choroidal neovascularization in a case of factor VIII deficiency: Ten-year follow-up
An unusual case of choroidal neovascularization in a young female with factor VIII deficiency is presented. The treatment course lasted 23 months. A favourable treatment outcome with restoration of the original visual acuity was achieved. The eye remained stable until the last follow-up, 10 years fo...
Autores principales: | Rishi, Pukhraj, Rishi, Ekta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008506/ https://www.ncbi.nlm.nih.gov/pubmed/29977729 http://dx.doi.org/10.3205/oc000085 |
Ejemplares similares
-
Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta
por: Rishi, Pukhraj, et al.
Publicado: (2012) -
Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis
por: Rishi, Pukhraj, et al.
Publicado: (2011) -
Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy
por: Rishi, Ekta, et al.
Publicado: (2010) -
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011) -
Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
por: Rishi, Pukhraj, et al.
Publicado: (2009)